The 2nd International Conference on Drug Discovery & Therapy: Dubai, February 1 - 4, 2010

Poster Presenter

Evaluation Of Gum Against Cutaneous Leishmaniasis In Mice
Mojtaba Taran, Nadia Asadi
Canada

Leishmania major causes zoonotic cutaneous leishmaniasis (ZCL) in many rural areas of Iran. CL can be associated with significant morbidity and occasional deforming scars. Recent circumstantial evidences are suggesting that an increasing number of Iranian patients with cutaneous leishmaniasis are unresponsive to meglumine antimoniate (Glucantime®). Pistacia atlantica is native plant in Iran (central, western, and eastern regions). Gum obtained Pistacia atlantica has been reported to possess considerable in vitro antimicrobial activity.

Male BALB/c mice were inoculated subcutaneously 2 × 106 L. major promastigotes (MHROM/IR/75/ER) at the base of tail. Mice were randomly divided into 3 groups. in group 1 Glucantime® was administered to the BALB/c mice in regimen of 60 mg per kg of body weight for 28 days by intraperitoneal injections per day, in group 2 the Gum of Pistacia atlantica var. kurdica were tested by rubbing of local lesions for 28 days, group 3 infected but non-treated.

Topically rubbing administration of Gum obtained Pistacia atlantica var. kurdica daily for 28 days like Glucantime® decreased skin lesion size in the BALB/c mice infected with L.major compared with that in the control(p<0.01). Treatment BALB/c mice with Gum obtained Pistacia atlantica var. kurdica and Glucantime® causes decrease number of parasitologicaly positive mice(p<0.05).

Our results shows that Gum obtained Pistacia atlantica var. kurdica can be used for controlling cutaneous leishmaniasis caused by L.major and inhibiting development of cutaneous leishmaniasis lesions.





[Webmaster]   Copyright © 2010 2nd International Conference on Drug Design & Therapy